Advisory Committee on Immunization Practices (ACIP), 4910-4911 [2014-01823]
Download as PDF
<![CDATA[
4910
Federal Register / Vol. 79, No. 20 / Thursday, January 30, 2014 / Notices
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Generic Clearance for the Collection
of Qualitative Feedback on Agency
Service Delivery—NEW—Centers for
Disease Control and Prevention (CDC),
National Center for Injury Prevention
and Control (NCIPC).
As part of a Federal Government-wide
effort to streamline the process to seek
feedback from the public on service
delivery, the CDC has submitted a
Generic Information Collection Request
(Generic ICR): ‘‘Generic Clearance for
the Collection of Qualitative Feedback
on Agency Service Delivery ’’ to OMB
for approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et
seq.).
To request additional information,
please contact Leroy A. Richardson,
Centers for Disease Control and
Prevention, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an email to
omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery
Abstract: The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
Average no. of
respondents
per activity
Type of collection
Focus Groups ..................................................................................................
Online Surveys ................................................................................................
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–01822 Filed 1–29–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices (ACIP)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting of the
aforementioned committee:
VerDate Mar<15>2010
18:24 Jan 29, 2014
Jkt 232001
Frm 00047
Fmt 4703
Sfmt 4703
Annual
frequency
per response
5,000
55,000
Times and Dates: 8:00 a.m.–6:00 p.m.,
February 26, 2014. 8:00 a.m.–3:00 p.m.,
February 27, 2014.
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton
Road NE., Building 19, Kent ‘‘Oz’’
Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited
only by the space available.
Purpose: The committee is charged
with advising the Director, CDC, on the
appropriate use of immunizing agents.
In addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for
administration to vaccine-eligible
children through the Vaccines for
Children (VFC) program, along with
schedules regarding the appropriate
periodicity, dosage, and
contraindications applicable to the
vaccines. Further, under provisions of
PO 00000
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
The Agency received no comments in
response to the 60-day notice published
in the Federal Register on December 22,
2010 (75 FR 80542).
This is a new collection of
information. Respondents will be
screened and selected from Individuals
and Households, Businesses,
Organizations, and/or State, Local or
Tribal Government. Below we provide
CDC’s projected annualized estimate for
the next three years. There is no cost to
respondents other than their time. The
estimated annualized burden hours for
this data collection activity are 18,750.
1
1
Average no. of
activities
Average hours
per response
1
1
1
15/60
the Affordable Care Act, at section 2713
of the Public Health Service Act,
immunization recommendations of the
ACIP that have been adopted by the
Director, CDC must be covered by
applicable health plans.
Matters To Be Discussed: The agenda
will include discussions on: human
papillomavirus vaccines, influenza,
pneumococcal conjugate vaccine, safety
of tetanus, diphtheria, and acellular
pertussis vaccine/pregnancy,
meningococcal vaccines, smallpox
vaccine, yellow fever vaccine, adult
immunization, and vaccine supply.
Recommendation votes are scheduled
for human papillomavirus vaccines and
influenza. Time will be available for
public comment.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Felicia Betancourt, National Center for
Immunization and Respiratory Diseases,
E:\FR\FM\30JAN1.SGM
30JAN1
Federal Register / Vol. 79, No. 20 / Thursday, January 30, 2014 / Notices
CDC, 1600 Clifton Road NE., MS–A27,
Atlanta, Georgia 30333, telephone 404/
639–8836; Email ACIP@CDC.GOV.
The meeting is webcast live via the
World Wide Web; for instructions and
more information on ACIP please visit
the ACIP Web site: https://www.cdc.gov/
vaccines/acip/.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2014–01823 Filed 1–29–14; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
mstockstill on DSK4VPTVN1PROD with NOTICES
Request for Nominations of
Candidates to Serve on the World
Trade Center Health Program
Scientific/Technical Advisory
Committee (the STAC or the
Committee), Centers for Disease
Control and Prevention, Department of
Health and Human Services
The CDC is soliciting nominations for
membership on the World Trade Center
(WTC) Health Program Scientific/
Technical Advisory Committee (STAC).
Title I of the James Zadroga 9/11
Health and Compensation Act of 2010
(Pub. L. 111–347) was enacted on
January 2, 2011, amending the Public
Health Service Act (PHS Act) by adding
Title XXXIII establishing the WTC
Health Program within HHS (Title
XXXIII of the PHS Act is codified at 42
U.S.C. 300mm to 300mm–61). Section
3302(a) of the PHS Act established the
WTC Health Program Scientific/
Technical Advisory Committee (STAC).
The STAC is governed by the provisions
of the Federal Advisory Committee Act,
as amended (Pub. L. 92–463, 5 U.S.C.
App.), which sets forth standards for the
formation and use of advisory
committees in the Executive Branch.
PHS Act Section 3302(a)(1) establishes
that the STAC will: Review scientific
and medical evidence and make
recommendations to the [WTC Program]
Administrator on additional WTC
Program eligibility criteria and on
additional WTC-related health
VerDate Mar<15>2010
18:24 Jan 29, 2014
Jkt 232001
conditions. Section 3341(c) of the PHS
Act requires the WTC Program
Administrator to also consult with the
STAC on research regarding certain
health conditions related to the
September 11 terrorist attacks. The
STAC may also be consulted on other
matters related to implementation and
improvement of the WTC Health
Program, as outlined in the PHS Act, at
the discretion of the WTC Program
Administrator. In accordance with
Section 3302(a)(2) of the PHS Act, the
WTC Program Administrator will
appoint the members of the committee,
which must include at least:
• 4 occupational physicians, at least
two of whom have experience treating
WTC rescue and recovery workers;
• 1 physician with expertise in
pulmonary medicine;
• 2 environmental medicine or
environmental health specialists;
• 2 representatives of WTC
responders;
• 2 representatives of certifiedeligible WTC survivors;
• 1 industrial hygienist;
• 1 toxicologist;
• 1 epidemiologist; and
• 1 mental health professional.
At this time the Administrator is
seeking nominations for members
fulfilling the following categories:
• occupational physician with
experience treating WTC rescue and
recovery workers;
• representative of WTC responders;
• representative of certified-eligible
WTC survivors;
• industrial hygienist;
• mental health professional.
Other members may be appointed at
the discretion of the WTC Program
Administrator.
A STAC member’s term appointment
may last 3 years. If a vacancy occurs, the
WTC Program Administrator may
appoint a new member who fulfills the
same membership category as the
predecessor. STAC members may be
appointed to successive terms. The
frequency of committee meetings shall
be determined by the WTC Program
Administrator based on program needs.
Meetings may occur up to four times a
year. Members are paid the Special
Government Employee rate of $250 per
day, and travel costs and per diem are
included and based on the Federal
Travel Regulations.
Any interested person or organization
may self-nominate or nominate one or
more qualified persons for membership.
Nominations must include the
following information:
• The nominee’s contact information
and current occupation or position;
• The nominee’s resume or
curriculum vitae, including prior or
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
4911
current membership on other National
Institute for Occupational Safety and
Health (NIOSH), CDC, or HHS advisory
committees or other relevant
organizations, associations, and
committees;
• The category of membership
(occupational physician with
experience treating WTC rescue and
recovery workers, representative of
WTC responders or certified-eligible
WTC survivors, industrial hygienist, or
mental health professional) that the
candidate is qualified to represent;
• A summary of the background,
experience, and qualifications that
demonstrates the nominee’s suitability
for the nominated membership category;
• Articles or other documents the
nominee has authored that indicate the
nominee’s knowledge and experience in
relevant subject categories; and
• A statement that the nominee is
aware of the nomination, is willing to
regularly attend and participate in
STAC meetings, and has no known
conflicts of interest that would preclude
membership on the Committee.
STAC members will be selected upon
the basis of their relevant experience
and competence in their respective
categorical fields. The information
received through this nomination
process, in addition to other relevant
sources of information, will assist the
WTC Program Administrator in
appointing members to serve on the
STAC. In selecting members, the WTC
Program Administrator will consider
individuals nominated in response to
this Federal Register notice as well as
other qualified individuals.
The CDC is committed to bringing
greater diversity of thought, perspective,
and experience to its advisory
committees. Nominees from all races,
genders, ages, and persons living with
disabilities are encouraged to apply.
Nominees must be U.S. citizens.
Candidates invited to serve will be
asked to submit the ‘‘Confidential
Financial Disclosure Report,’’ OGE
Form 450. This form is used by CDC to
determine whether there is a financial
conflict between that person’s private
interests and activities and their public
responsibilities as a Special Government
Employee as well as any appearance of
a loss of impartiality, as defined by
Federal regulation. The form may be
viewed and downloaded at https://
www.oge.gov/Forms-Library/OGE-Form450-Confidential-Financial-DisclosureReport/. This form should not be
submitted as part of a nomination.
DATES: Nominations must be submitted
(postmarked or electronically received)
by March 14, 2014.
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 79, Number 20 (Thursday, January 30, 2014)]
[Notices]
[Pages 4910-4911]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-01823]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee:
Times and Dates: 8:00 a.m.-6:00 p.m., February 26, 2014. 8:00 a.m.-
3:00 p.m., February 27, 2014.
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton
Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia
30333.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with advising the Director, CDC,
on the appropriate use of immunizing agents. In addition, under 42
U.S.C. 1396s, the committee is mandated to establish and periodically
review and, as appropriate, revise the list of vaccines for
administration to vaccine-eligible children through the Vaccines for
Children (VFC) program, along with schedules regarding the appropriate
periodicity, dosage, and contraindications applicable to the vaccines.
Further, under provisions of the Affordable Care Act, at section 2713
of the Public Health Service Act, immunization recommendations of the
ACIP that have been adopted by the Director, CDC must be covered by
applicable health plans.
Matters To Be Discussed: The agenda will include discussions on:
human papillomavirus vaccines, influenza, pneumococcal conjugate
vaccine, safety of tetanus, diphtheria, and acellular pertussis
vaccine/pregnancy, meningococcal vaccines, smallpox vaccine, yellow
fever vaccine, adult immunization, and vaccine supply. Recommendation
votes are scheduled for human papillomavirus vaccines and influenza.
Time will be available for public comment.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Felicia Betancourt, National
Center for Immunization and Respiratory Diseases,
[[Page 4911]]
CDC, 1600 Clifton Road NE., MS-A27, Atlanta, Georgia 30333, telephone
404/639-8836; Email ACIP@CDC.GOV.
The meeting is webcast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: https://www.cdc.gov/vaccines/acip/.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-01823 Filed 1-29-14; 8:45 am]
BILLING CODE 4160-18-P
